Chronic treatment with Δ9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin.: Implications for vulnerability to drug addiction

被引:99
作者
Lamarque, S
Taghzouti, K
Simon, H
机构
[1] Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France
[2] Fac Sci Rabat, Lab Physiol Anim, Rabat, Morocco
关键词
cross-sensitization; Delta(9)-THC; amphetamine; heroin; chronic treatment; locomotor activity;
D O I
10.1016/S0028-3908(01)00039-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabis sativa preparations are some of the most widely used illicit recreational drugs. In addition to their direct addictive potential, cannabinoids may influence the sensitivity to other drugs. The aim of the present study was to determine if a cross-sensitization between Delta (9)-tetrahydrocannabinol (Delta (9)-THC) and other drugs (amphetamine and heroin) could be demonstrated. We examined the effects of a chronic treatment with Delta (9)-THC (0.6. 3 and 15 mg/kg, ip) on the locomotor response to amphetamine (1 mg/kg. ip) and heroin (1 mg/kg, ip). Chronic treatment with Delta (9)-THC resulted in tolerance to the initial hypothermic and anorexic effects. Pre-treatment with Delta (9)-THC increased the locomotor responses to amphetamine and heroin. This cross-sensitization was time-dependent as it was observed three days after the last injection of Delta (9)-THC for amphetamine, and a relatively long time after the end of chronic treatment (41 days) for heroin. Moreover, the enhanced response to amphetamine or heroin was noted in some individuals only: the high-responder rats (HR). These animals have previously been shown to be vulnerable to drug taking behaviors. It is hypothesised that repeated use of Cannabis derivates may facilitate progression to the consumption of other illicit drugs in vulnerable individuals. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:118 / 129
页数:12
相关论文
共 95 条
[1]   CANNABINOID PRECIPITATED WITHDRAWAL BY THE SELECTIVE CANNABINOID RECEPTOR ANTAGONIST, SR 141716A [J].
ACETO, MD ;
SCATES, SM ;
LOWE, JA ;
MARTIN, BR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 282 (1-3) :R1-R2
[2]   TOLERANCE TO EFFECTS OF DELTA9-TETRAHYDROCANNABINOL IN MICE ON INTESTINAL MOTILITY, TEMPERATURE AND LOCOMOTOR ACTIVITY [J].
ANDERSON, PF ;
JACKSON, DM ;
CHESHER, GB ;
MALOR, R .
PSYCHOPHARMACOLOGIA, 1975, 43 (01) :31-36
[3]   Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine [J].
Arnold, JC ;
Topple, AN ;
Hunt, GE ;
McGregor, IS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (01) :9-16
[4]   Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor [J].
Beltramo, M ;
de Fonseca, FR ;
Navarro, M ;
Calignano, A ;
Gorriti, MA ;
Grammatikopoulos, G ;
Sadile, AG ;
Giuffrida, A ;
Piomelli, D .
JOURNAL OF NEUROSCIENCE, 2000, 20 (09) :3401-3407
[5]  
BLOOM AS, 1978, RES COMMUN CHEM PATH, V20, P51
[6]   REGIONAL BRAIN HOMOVANILLIC-ACID FOLLOWING DELTA-9-TETRAHYDROCANNABINOL AND COCAINE [J].
BOWERS, MB ;
HOFFMAN, FJ .
BRAIN RESEARCH, 1986, 366 (1-2) :405-407
[7]   POTENTIATION OF AMPHETAMINE-INDUCED AROUSAL BY STARVATION [J].
CAMPBELL, BA ;
FIBIGER, HC .
NATURE, 1971, 233 (5319) :424-&
[8]   EVALUATION OF A SUSPENSION SYSTEM FOR INTRAVENOUS SELF-ADMINISTRATION STUDIES OF WATER-INSOLUBLE COMPOUNDS IN RHESUS-MONKEY [J].
CARNEY, JM ;
UWAYDAH, IM ;
BALSTER, RL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1977, 7 (04) :357-364
[9]   THC DOES NOT AFFECT STRIATAL DOPAMINE RELEASE - MICRODIALYSIS IN FREELY MOVING RATS [J].
CASTANEDA, E ;
MOSS, DE ;
ODDIE, SD ;
WHISHAW, IQ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (03) :587-591
[10]   Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats [J].
Chaperon, F ;
Soubrié, P ;
Puech, AJ ;
Thiébot, MH .
PSYCHOPHARMACOLOGY, 1998, 135 (04) :324-332